Cerestat

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameCerestat
Drug Alias NameCNS-1102Aptiganel
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlutamate [NMDA] receptor antagonists
TargetsGlutamate [NMDA] receptor
Therapy Area/IndicationsStrokeBrain Injuries
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesCenes
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCenes
Active IndicationsN/A
Inactive IndicationsStrokeBrain Injuries

Other Information

ATC CodeN/A
Related LinksWikipedia